FDA’s broad approval of chemical abortion drug puts Alaska mothers, unborn babies at risk
The U.S. Food and Drug Administration (FDA) announced earlier this week that it is removing its requirement for mifepristone to be administered in the presence of a certified health care provider (HCP). Mifepristone, which is the first of two drugs used in